Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09CPC
|
||||
Former ID |
DNC004505
|
||||
Drug Name |
6-Pyridin-3-yl-3,4-dihydro-1H-quinolin-2-one
|
||||
Synonyms |
6-Pyridin-3-yl-3,4-dihydroquinolin-2(1H)-on
|
||||
Indication | Discovery agent | Investigative | [526726] | ||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1CC(=O)NC2=C1C=C(C=C2)C3=CN=CC=C3
|
||||
InChI |
1S/C14H12N2O/c17-14-6-4-11-8-10(3-5-13(11)16-14)12-2-1-7-15-9-12/h1-3,5,7-9H,4,6H2,(H,16,17)
|
||||
InChIKey |
MPGBYGNPFRLHAO-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | CGMP-inhibited 3',5'-cyclic phosphodiesterase A | Target Info | Inhibitor | [526726] | |
Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [529834] | ||
PathWhiz Pathway | Steroidogenesis | ||||
References | |||||
Ref 526726 | J Med Chem. 1992 Feb 21;35(4):620-8.3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase. | ||||
Ref 529834 | J Med Chem. 2008 Dec 25;51(24):8077-87.In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivatives. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.